nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—IL1B—bipolar disorder	0.769	1	CbGaD
Minocycline—CYCS—blood plasma—bipolar disorder	0.00844	0.0978	CbGeAlD
Minocycline—CASP3—blood plasma—bipolar disorder	0.00723	0.0838	CbGeAlD
Minocycline—IL1B—blood plasma—bipolar disorder	0.00577	0.0669	CbGeAlD
Minocycline—SLC22A8—urine—bipolar disorder	0.00493	0.0572	CbGeAlD
Minocycline—MMP9—blood plasma—bipolar disorder	0.00481	0.0558	CbGeAlD
Minocycline—CASP3—adrenal cortex—bipolar disorder	0.00367	0.0425	CbGeAlD
Minocycline—CASP1—thyroid gland—bipolar disorder	0.0031	0.0359	CbGeAlD
Minocycline—CYCS—thyroid gland—bipolar disorder	0.00298	0.0346	CbGeAlD
Minocycline—VEGFA—adrenal cortex—bipolar disorder	0.00288	0.0334	CbGeAlD
Minocycline—CASP1—nervous system—bipolar disorder	0.00261	0.0302	CbGeAlD
Minocycline—CASP3—thyroid gland—bipolar disorder	0.00255	0.0296	CbGeAlD
Minocycline—CYCS—nervous system—bipolar disorder	0.00251	0.0291	CbGeAlD
Minocycline—CASP1—cerebellum—bipolar disorder	0.00245	0.0284	CbGeAlD
Minocycline—CYCS—cerebellum—bipolar disorder	0.00236	0.0274	CbGeAlD
Minocycline—CASP3—nervous system—bipolar disorder	0.00215	0.0249	CbGeAlD
Minocycline—IL1B—thyroid gland—bipolar disorder	0.00204	0.0237	CbGeAlD
Minocycline—CASP3—cerebellum—bipolar disorder	0.00202	0.0234	CbGeAlD
Minocycline—VEGFA—thyroid gland—bipolar disorder	0.00201	0.0233	CbGeAlD
Minocycline—CASP1—brain—bipolar disorder	0.00199	0.0231	CbGeAlD
Minocycline—CYCS—brain—bipolar disorder	0.00192	0.0222	CbGeAlD
Minocycline—IL1B—nervous system—bipolar disorder	0.00172	0.0199	CbGeAlD
Minocycline—CASP3—brain—bipolar disorder	0.00164	0.019	CbGeAlD
Minocycline—VEGFA—cerebellum—bipolar disorder	0.00159	0.0184	CbGeAlD
Minocycline—MMP9—nervous system—bipolar disorder	0.00143	0.0166	CbGeAlD
Minocycline—ALOX5—thyroid gland—bipolar disorder	0.00134	0.0156	CbGeAlD
Minocycline—IL1B—brain—bipolar disorder	0.00131	0.0152	CbGeAlD
Minocycline—VEGFA—brain—bipolar disorder	0.00129	0.015	CbGeAlD
Minocycline—ALOX5—nervous system—bipolar disorder	0.00113	0.0131	CbGeAlD
Minocycline—MMP9—brain—bipolar disorder	0.00109	0.0127	CbGeAlD
Minocycline—ALOX5—cerebellum—bipolar disorder	0.00106	0.0123	CbGeAlD
Minocycline—SLC22A7—brain—bipolar disorder	0.00101	0.0117	CbGeAlD
Minocycline—SLC22A6—brain—bipolar disorder	0.000977	0.0113	CbGeAlD
Minocycline—ALOX5—brain—bipolar disorder	0.000865	0.01	CbGeAlD
Minocycline—SLC22A8—nervous system—bipolar disorder	0.000765	0.00887	CbGeAlD
Minocycline—SLC22A8—brain—bipolar disorder	0.000585	0.00678	CbGeAlD
Minocycline—VEGFA—Axon guidance—NCAN—bipolar disorder	0.000247	0.00171	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—INS—bipolar disorder	0.000246	0.0017	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—SNAP25—bipolar disorder	0.000245	0.00169	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—GATA3—bipolar disorder	0.000245	0.00169	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—SLC6A4—bipolar disorder	0.000245	0.00169	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—NTRK2—bipolar disorder	0.000243	0.00168	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—GSK3A—bipolar disorder	0.000242	0.00167	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—ANK3—bipolar disorder	0.000242	0.00167	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—GSK3A—bipolar disorder	0.000241	0.00167	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—INS—bipolar disorder	0.000239	0.00165	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—NTRK2—bipolar disorder	0.000238	0.00164	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—NR3C1—bipolar disorder	0.000236	0.00163	CbGpPWpGaD
Minocycline—SLC22A8—SLC-mediated transmembrane transport—SLC5A3—bipolar disorder	0.000235	0.00162	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—AKR1C4—bipolar disorder	0.000232	0.0016	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.000229	0.00158	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—HTR2A—bipolar disorder	0.000226	0.00156	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—ADCY2—bipolar disorder	0.000221	0.00153	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—SERPINA1—bipolar disorder	0.000218	0.0015	CbGpPWpGaD
Minocycline—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—bipolar disorder	0.000217	0.0015	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—GRIN1—bipolar disorder	0.000216	0.00149	CbGpPWpGaD
Minocycline—CASP3—BDNF signaling pathway—GSK3B—bipolar disorder	0.000214	0.00148	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—HLA-E—bipolar disorder	0.000213	0.00147	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—TRPC3—bipolar disorder	0.000211	0.00146	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	0.000209	0.00144	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—NRG1—bipolar disorder	0.000208	0.00144	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—TRPM2—bipolar disorder	0.000208	0.00144	CbGpPWpGaD
Minocycline—CYCS—Metabolism—IMPA1—bipolar disorder	0.000204	0.00141	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—NCAN—bipolar disorder	0.000203	0.0014	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—IL1B—bipolar disorder	0.000202	0.00139	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—GSK3A—bipolar disorder	0.000201	0.00139	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—GSK3A—bipolar disorder	0.000199	0.00138	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—ANK3—bipolar disorder	0.000199	0.00137	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—NTRK1—bipolar disorder	0.000198	0.00137	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—CACNB2—bipolar disorder	0.000197	0.00136	CbGpPWpGaD
Minocycline—SLC22A6—SLC-mediated transmembrane transport—SLC5A3—bipolar disorder	0.000196	0.00135	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—HLA-E—bipolar disorder	0.000191	0.00132	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—GRIN1—bipolar disorder	0.000187	0.00129	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—IMPA2—bipolar disorder	0.000186	0.00128	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—DGKH—bipolar disorder	0.000185	0.00128	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—IL1B—bipolar disorder	0.000185	0.00128	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—MAOA—bipolar disorder	0.000184	0.00127	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—TRPC3—bipolar disorder	0.000184	0.00127	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—ADCY2—bipolar disorder	0.000183	0.00126	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—CACNA1C—bipolar disorder	0.00018	0.00124	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—IL1B—bipolar disorder	0.000178	0.00123	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—BDNF—bipolar disorder	0.000178	0.00123	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—NCAN—bipolar disorder	0.000176	0.00122	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—TRPM2—bipolar disorder	0.000173	0.0012	CbGpPWpGaD
Minocycline—CYCS—Metabolism—NDUFV2—bipolar disorder	0.000173	0.0012	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—ANK3—bipolar disorder	0.000173	0.00119	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—CACNB2—bipolar disorder	0.000171	0.00118	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—NRG1—bipolar disorder	0.00017	0.00118	CbGpPWpGaD
Minocycline—CYCS—Metabolism—AKR1C4—bipolar disorder	0.000168	0.00116	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—NTRK1—bipolar disorder	0.000165	0.00114	CbGpPWpGaD
Minocycline—IL1B—Immune System—MB21D1—bipolar disorder	0.000164	0.00113	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—GSK3B—bipolar disorder	0.000163	0.00113	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—S100B—bipolar disorder	0.000159	0.0011	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—NR3C1—bipolar disorder	0.000157	0.00108	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	0.000157	0.00108	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—CACNA1C—bipolar disorder	0.000156	0.00108	CbGpPWpGaD
Minocycline—SLC22A11—SLC-mediated transmembrane transport—SLC6A3—bipolar disorder	0.000155	0.00107	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—GRIN1—bipolar disorder	0.000154	0.00106	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—IL1B—bipolar disorder	0.000153	0.00106	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.000152	0.00105	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—BDNF—bipolar disorder	0.000151	0.00104	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—GSK3B—bipolar disorder	0.000151	0.00104	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TRPC3—bipolar disorder	0.000151	0.00104	CbGpPWpGaD
Minocycline—CYCS—Metabolism—NR1D1—bipolar disorder	0.000151	0.00104	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.00015	0.00104	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—HTR2A—bipolar disorder	0.00015	0.00104	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—IL1B—bipolar disorder	0.000148	0.00102	CbGpPWpGaD
Minocycline—CYCS—Metabolism—NCAN—bipolar disorder	0.000144	0.000996	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—GRIN2B—bipolar disorder	0.000142	0.000981	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	0.000142	0.000981	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	0.000141	0.000977	CbGpPWpGaD
Minocycline—CYCS—Metabolism—SLC5A3—bipolar disorder	0.000141	0.000976	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—NRG1—bipolar disorder	0.000141	0.000971	CbGpPWpGaD
Minocycline—SLC22A7—SLC-mediated transmembrane transport—SLC6A3—bipolar disorder	0.00014	0.000969	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—CACNB2—bipolar disorder	0.00014	0.000969	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—IL1B—bipolar disorder	0.000139	0.000961	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—IL1B—bipolar disorder	0.000134	0.000925	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—GRIN1—bipolar disorder	0.000134	0.000923	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TRPC3—bipolar disorder	0.000131	0.000904	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TRPC3—bipolar disorder	0.000128	0.000887	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—CACNA1C—bipolar disorder	0.000128	0.000886	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—IL1B—bipolar disorder	0.000128	0.000885	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—IMPA1—bipolar disorder	0.000126	0.000868	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—GSK3B—bipolar disorder	0.000124	0.000853	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—GRIN2B—bipolar disorder	0.000123	0.000852	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	0.000123	0.000848	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—CACNB2—bipolar disorder	0.000122	0.000841	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	0.000119	0.000824	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.000119	0.000819	CbGpPWpGaD
Minocycline—SLC22A8—SLC-mediated transmembrane transport—SLC6A3—bipolar disorder	0.000118	0.000814	CbGpPWpGaD
Minocycline—CASP1—Immune System—GSK3A—bipolar disorder	0.000116	0.000801	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—AKR1C4—bipolar disorder	0.000113	0.000783	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—SERPINA1—bipolar disorder	0.000112	0.000776	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—CACNA1C—bipolar disorder	0.000111	0.000769	CbGpPWpGaD
Minocycline—CASP1—Immune System—HLA-E—bipolar disorder	0.000111	0.000769	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.000108	0.000743	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—NDUFV2—bipolar disorder	0.000107	0.000738	CbGpPWpGaD
Minocycline—CASP1—Immune System—ADCY2—bipolar disorder	0.000106	0.000735	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—DGKH—bipolar disorder	0.000104	0.00072	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—AKR1C4—bipolar disorder	0.000103	0.000715	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—GSK3B—bipolar disorder	0.000103	0.000713	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CLOCK—bipolar disorder	0.000102	0.000706	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—GSK3B—bipolar disorder	0.000102	0.000705	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—GRIN2B—bipolar disorder	0.000101	0.0007	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	9.96e-05	0.000688	CbGpPWpGaD
Minocycline—CYCS—Metabolism—TPH2—bipolar disorder	9.96e-05	0.000688	CbGpPWpGaD
Minocycline—CYCS—Metabolism—TSHB—bipolar disorder	9.96e-05	0.000688	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CACNB2—bipolar disorder	9.96e-05	0.000688	CbGpPWpGaD
Minocycline—SLC22A6—SLC-mediated transmembrane transport—SLC6A3—bipolar disorder	9.84e-05	0.00068	CbGpPWpGaD
Minocycline—CYCS—Metabolism—DPYD—bipolar disorder	9.8e-05	0.000677	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—GATA3—bipolar disorder	9.55e-05	0.000659	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—DRD5—bipolar disorder	9.54e-05	0.000659	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—RGS4—bipolar disorder	9.35e-05	0.000646	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—NR1D1—bipolar disorder	9.3e-05	0.000642	CbGpPWpGaD
Minocycline—CASP1—Immune System—S100B—bipolar disorder	9.28e-05	0.000641	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CACNA1C—bipolar disorder	9.11e-05	0.000629	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—TRPC3—bipolar disorder	9.05e-05	0.000625	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL1B—bipolar disorder	8.9e-05	0.000615	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—NCAN—bipolar disorder	8.89e-05	0.000614	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PIK3C2A—bipolar disorder	8.88e-05	0.000613	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—GRIN2B—bipolar disorder	8.8e-05	0.000608	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—SLC5A3—bipolar disorder	8.71e-05	0.000602	CbGpPWpGaD
Minocycline—CASP1—Immune System—NRG1—bipolar disorder	8.19e-05	0.000565	CbGpPWpGaD
Minocycline—CYCS—Metabolism—SNAP25—bipolar disorder	7.96e-05	0.00055	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—GSK3B—bipolar disorder	7.94e-05	0.000548	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AKR1C4—bipolar disorder	7.87e-05	0.000543	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	7.86e-05	0.000543	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—ADCY2—bipolar disorder	7.8e-05	0.000539	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—GSK3B—bipolar disorder	7.76e-05	0.000536	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—TRPC3—bipolar disorder	7.55e-05	0.000521	CbGpPWpGaD
Minocycline—IL1B—Immune System—GSK3A—bipolar disorder	7.25e-05	0.000501	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—DGKH—bipolar disorder	7.24e-05	0.0005	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TRPC3—bipolar disorder	7.23e-05	0.000499	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	7.13e-05	0.000492	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—ADCY2—bipolar disorder	7.08e-05	0.000489	CbGpPWpGaD
Minocycline—CYCS—Metabolism—ADCY2—bipolar disorder	7.05e-05	0.000487	CbGpPWpGaD
Minocycline—IL1B—Immune System—HLA-E—bipolar disorder	6.96e-05	0.000481	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ADM—bipolar disorder	6.9e-05	0.000476	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AKR1C4—bipolar disorder	6.83e-05	0.000472	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—GSK3B—bipolar disorder	6.74e-05	0.000465	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PDE4B—bipolar disorder	6.72e-05	0.000464	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TSHB—bipolar disorder	6.72e-05	0.000464	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TACR1—bipolar disorder	6.72e-05	0.000464	CbGpPWpGaD
Minocycline—IL1B—Immune System—ADCY2—bipolar disorder	6.66e-05	0.00046	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—DRD5—bipolar disorder	6.62e-05	0.000457	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RGS4—bipolar disorder	6.49e-05	0.000448	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CLOCK—bipolar disorder	6.3e-05	0.000435	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—DGKH—bipolar disorder	6.28e-05	0.000434	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—TSHB—bipolar disorder	6.14e-05	0.000424	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—TPH2—bipolar disorder	6.14e-05	0.000424	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CACNB2—bipolar disorder	6.14e-05	0.000424	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—DPYD—bipolar disorder	6.04e-05	0.000417	CbGpPWpGaD
Minocycline—CYCS—Metabolism—COMT—bipolar disorder	6.03e-05	0.000417	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	5.99e-05	0.000414	CbGpPWpGaD
Minocycline—CYCS—Metabolism—MAOA—bipolar disorder	5.99e-05	0.000414	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—ADCY2—bipolar disorder	5.95e-05	0.000411	CbGpPWpGaD
Minocycline—CASP1—Immune System—GSK3B—bipolar disorder	5.94e-05	0.00041	CbGpPWpGaD
Minocycline—IL1B—Immune System—S100B—bipolar disorder	5.8e-05	0.0004	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—DRD5—bipolar disorder	5.75e-05	0.000397	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RGS4—bipolar disorder	5.64e-05	0.000389	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CACNA1C—bipolar disorder	5.61e-05	0.000388	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HTR1A—bipolar disorder	5.56e-05	0.000384	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—GSK3B—bipolar disorder	5.54e-05	0.000382	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TAC1—bipolar disorder	5.48e-05	0.000378	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PIK3C2A—bipolar disorder	5.47e-05	0.000378	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—INS—bipolar disorder	5.46e-05	0.000377	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	5.4e-05	0.000373	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—DRD1—bipolar disorder	5.37e-05	0.000371	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HTR2C—bipolar disorder	5.37e-05	0.000371	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NTRK2—bipolar disorder	5.23e-05	0.000361	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—DRD3—bipolar disorder	5.2e-05	0.000359	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GSK3A—bipolar disorder	5.18e-05	0.000358	CbGpPWpGaD
Minocycline—IL1B—Immune System—NRG1—bipolar disorder	5.12e-05	0.000353	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—DRD4—bipolar disorder	5.05e-05	0.000349	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TRPC3—bipolar disorder	5.02e-05	0.000347	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	5e-05	0.000345	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—ADCY2—bipolar disorder	4.97e-05	0.000343	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—SNAP25—bipolar disorder	4.91e-05	0.000339	CbGpPWpGaD
Minocycline—CYCS—Metabolism—MTHFR—bipolar disorder	4.88e-05	0.000337	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—GSK3B—bipolar disorder	4.81e-05	0.000332	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ADM—bipolar disorder	4.79e-05	0.000331	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ADCY2—bipolar disorder	4.75e-05	0.000328	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—INS—bipolar disorder	4.74e-05	0.000328	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TCF7L2—bipolar disorder	4.74e-05	0.000327	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—DRD2—bipolar disorder	4.7e-05	0.000325	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TSHB—bipolar disorder	4.66e-05	0.000322	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PDE4B—bipolar disorder	4.66e-05	0.000322	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TACR1—bipolar disorder	4.66e-05	0.000322	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL1B—bipolar disorder	4.37e-05	0.000302	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TRPC3—bipolar disorder	4.36e-05	0.000301	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ADCY2—bipolar disorder	4.34e-05	0.0003	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NTRK1—bipolar disorder	4.26e-05	0.000294	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ADM—bipolar disorder	4.16e-05	0.000287	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—S100B—bipolar disorder	4.14e-05	0.000286	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TSHB—bipolar disorder	4.05e-05	0.00028	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TACR1—bipolar disorder	4.05e-05	0.00028	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PDE4B—bipolar disorder	4.05e-05	0.00028	CbGpPWpGaD
Minocycline—CYCS—Metabolism—POMC—bipolar disorder	3.9e-05	0.000269	CbGpPWpGaD
Minocycline—CYCS—Metabolism—INS—bipolar disorder	3.88e-05	0.000268	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HTR1A—bipolar disorder	3.86e-05	0.000267	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TAC1—bipolar disorder	3.8e-05	0.000263	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HTR2C—bipolar disorder	3.73e-05	0.000258	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—DRD1—bipolar disorder	3.73e-05	0.000258	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—COMT—bipolar disorder	3.72e-05	0.000257	CbGpPWpGaD
Minocycline—IL1B—Immune System—GSK3B—bipolar disorder	3.71e-05	0.000257	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—MAOA—bipolar disorder	3.69e-05	0.000255	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NRG1—bipolar disorder	3.65e-05	0.000252	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NTRK2—bipolar disorder	3.63e-05	0.000251	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—DRD3—bipolar disorder	3.61e-05	0.000249	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GSK3A—bipolar disorder	3.6e-05	0.000248	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—DRD4—bipolar disorder	3.51e-05	0.000242	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HTR1A—bipolar disorder	3.35e-05	0.000231	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TAC1—bipolar disorder	3.3e-05	0.000228	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ADCY2—bipolar disorder	3.3e-05	0.000228	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HTR2A—bipolar disorder	3.3e-05	0.000228	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TCF7L2—bipolar disorder	3.29e-05	0.000227	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—DRD2—bipolar disorder	3.27e-05	0.000226	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HTR2C—bipolar disorder	3.24e-05	0.000224	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—DRD1—bipolar disorder	3.24e-05	0.000224	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NTRK2—bipolar disorder	3.15e-05	0.000217	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—DRD3—bipolar disorder	3.14e-05	0.000217	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GSK3A—bipolar disorder	3.12e-05	0.000216	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—DRD4—bipolar disorder	3.04e-05	0.00021	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—MTHFR—bipolar disorder	3.01e-05	0.000208	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NTRK1—bipolar disorder	2.96e-05	0.000204	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—S100B—bipolar disorder	2.87e-05	0.000199	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ADCY2—bipolar disorder	2.86e-05	0.000198	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TCF7L2—bipolar disorder	2.85e-05	0.000197	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—DRD2—bipolar disorder	2.84e-05	0.000196	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GSK3B—bipolar disorder	2.65e-05	0.000183	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—POMC—bipolar disorder	2.63e-05	0.000182	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—INS—bipolar disorder	2.62e-05	0.000181	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NTRK1—bipolar disorder	2.57e-05	0.000177	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NRG1—bipolar disorder	2.54e-05	0.000175	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—S100B—bipolar disorder	2.5e-05	0.000172	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—POMC—bipolar disorder	2.4e-05	0.000166	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—INS—bipolar disorder	2.39e-05	0.000165	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HTR2A—bipolar disorder	2.29e-05	0.000158	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NRG1—bipolar disorder	2.2e-05	0.000152	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HTR2A—bipolar disorder	1.99e-05	0.000137	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GSK3B—bipolar disorder	1.84e-05	0.000127	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—POMC—bipolar disorder	1.83e-05	0.000126	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—INS—bipolar disorder	1.82e-05	0.000125	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GSK3B—bipolar disorder	1.6e-05	0.00011	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—POMC—bipolar disorder	1.59e-05	0.00011	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—INS—bipolar disorder	1.58e-05	0.000109	CbGpPWpGaD
